Aiden Kooyman, BS

University of British Columbia
Vancouver, BC

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 124 - Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Secondary Analysis of the Phase II SABR-5 Trial

  Sunday, September 29, 2024
  2:55 PM – 3:05 PM ET